Photys
Photys Therapeutics | Control of protein post-translational modifications
Waltham, United States · $75.0M raised
- Headquarters
- Waltham, Massachusetts
- Employees
- 11–50
- Business Model
- B2B
- Website
- photys.com
- Total Funding
- $75.0M
- Last Round
- $75.0M Series ASep 2022
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Photys Therapeutics is a proximity-based therapeutics company advancing a new generation of targeted protein modulation medicines. Through its proprietary PHICS™ and tPRIME™ platforms, together with deep expertise in PROTACs, Photys is building a pipeline of differentiated therapies for autoimmune, inflammatory, oncology, and cardiometabolic diseases.
Summary
Photys is a Biotech company based in Waltham, United States. It has raised $75.0M in total across 1 round, most recently a $75.0M Series A round in Sep 2022. Investors include MPM Capital, Omega Funds and Longwood Fund.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sep 2022
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/photys"><img src="https://indexed.vc/api/badge/company/photys" alt="Photys on Indexed.vc" width="260" height="76" /></a>